Page last updated: 2024-10-26

disulfiram and Systemic Inflammatory Response Syndrome

disulfiram has been researched along with Systemic Inflammatory Response Syndrome in 1 studies

Systemic Inflammatory Response Syndrome: A systemic inflammatory response to a variety of clinical insults, characterized by two or more of the following conditions: (1) fever

Research Excerpts

ExcerptRelevanceReference
"Lactoferrin (LF) is a multifunctional glycoprotein with potent antibacterial and anti-inflammatory activities that acts by neutralizing circulating endotoxins and activating cellular responses."1.62Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases. ( Fang, YF; Huang, YZ; Ou, AT; Tang, XP; Wang, R; Zhang, JX; Zhang, M; Zhao, PF; Zhao, YG, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ou, AT1
Zhang, JX1
Fang, YF1
Wang, R1
Tang, XP1
Zhao, PF1
Zhao, YG1
Zhang, M1
Huang, YZ1

Other Studies

1 other study available for disulfiram and Systemic Inflammatory Response Syndrome

ArticleYear
Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases.
    Acta pharmacologica Sinica, 2021, Volume: 42, Issue:11

    Topics: Acetaldehyde Dehydrogenase Inhibitors; Animals; Anti-Inflammatory Agents; Biomimetic Materials; Coli

2021